<DOC>
	<DOCNO>NCT01474967</DOCNO>
	<brief_summary>Polycystic ovarian syndrome ( PCOS ) common cause anovulatory infertility cause menstrual disruption 6.6-6.8 % woman reproductive age characterize insulin resistance , hyperinsulinemia , hyperandrogenism anovulation . The gaol study assess effect metformin menstrual disorder lipid profile woman PCOS bandarabbas .</brief_summary>
	<brief_title>Effect Dosage Metformin Menstruation Lipid Profile Women With Polycystic Ovary Syndrome</brief_title>
	<detailed_description>Poly cystic ovarian syndrome ( PCOS ) common hormonal disorder woman affect 6.6-6.8 % woman f reproductive age . PCOS associate broad range clinical , hormonal metabolic disorder consist hirsutism , Obesity , Acne elevate male hormone , anovulatory cycle , dyslipidemia infertility . Metformin oral hyperglycemic agent witch decrease insulin resistance improve serum glucose level diabetic patient anovulatory cyle woman PCOS . The goal study evaluate efficacy different dosage metformin menstruation lipid profile woman PCOS banda-abbas .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Women PCOS avoid participate study</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>polycystic ovary syndrome</keyword>
	<keyword>lipid profile</keyword>
	<keyword>metformin</keyword>
</DOC>